Sandbox g09: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) (Created page with "===Mycotic aneurysm=== {{Details-tx|Mycotic aneurysm#Treatment}} * '''Empiric antimicrobial therapy''' :* Preferred regimen: Vancomycin 2 g/day IV divided q6-12h targetin...") |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
=== | * Viral pericarditis<ref name="pmid15120056">{{cite journal| author=Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y et al.| title=Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. | journal=Eur Heart J | year= 2004 | volume= 25 | issue= 7 | pages= 587-610 | pmid=15120056 | doi=10.1016/j.ehj.2004.02.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15120056 }} </ref> | ||
:* '''CMV pericarditis''' | |||
::* Preferred regimen: [[immunoglobulin]] 1 time per day 4 ml/kg on day 0, 4, and 8; 2 ml/kg on day 12 and 16. | |||
* ''' | ::: Note: Symptomatic treatment is given to the patients with viral [[pericarditis]] while in large effusions and [[cardiac tamponade]] [[pericardiocentesis]] is necessary. The use of [[corticosteroid]] therapy is contraindicated except in patients with secondary [[tuberculous pericarditis]], as an adjunct to [[tuberculosis]] treatment. Drainage, if needed is done. | ||
:* Preferred regimen: [[ | :* '''Coxsackie B pericarditis''' | ||
:* | ::* Preferred regimen: [[ Interferon]] alpha or beta 2,5 Mio. IU/m2 surface area s.c. 3×per week. | ||
:: Note: | ::: Note: Symptomatic treatment is given to the patients with viral [[pericarditis]] while in large effusions and [[cardiac tamponade]] [[pericardiocentesis]] is necessary. The use of [[corticosteroid]] therapy is contraindicated except in patients with secondary [[tuberculous pericarditis]], as an adjunct to [[tuberculosis]] treatment. Drainage, if needed is done. | ||
:* '''Adenovirus and parvovirus B19 perimyocarditis''' | |||
::* Preferred regimen: [[Immunoglobulin]] 10 g intravenously at day 1 and 3 for 6–8 hours | |||
::: Note: Symptomatic treatment is given to the patients with viral [[pericarditis]] while in large effusions and [[cardiac tamponade]] [[pericardiocentesis]] is necessary. The use of [[corticosteroid]] therapy is contraindicated except in patients with secondary [[tuberculous pericarditis]], as an adjunct to [[tuberculosis]] treatment. Drainage, if needed is done. | |||
Revision as of 21:37, 28 May 2015
- Viral pericarditis[1]
- CMV pericarditis
- Preferred regimen: immunoglobulin 1 time per day 4 ml/kg on day 0, 4, and 8; 2 ml/kg on day 12 and 16.
- Note: Symptomatic treatment is given to the patients with viral pericarditis while in large effusions and cardiac tamponade pericardiocentesis is necessary. The use of corticosteroid therapy is contraindicated except in patients with secondary tuberculous pericarditis, as an adjunct to tuberculosis treatment. Drainage, if needed is done.
- Coxsackie B pericarditis
- Preferred regimen: Interferon alpha or beta 2,5 Mio. IU/m2 surface area s.c. 3×per week.
- Note: Symptomatic treatment is given to the patients with viral pericarditis while in large effusions and cardiac tamponade pericardiocentesis is necessary. The use of corticosteroid therapy is contraindicated except in patients with secondary tuberculous pericarditis, as an adjunct to tuberculosis treatment. Drainage, if needed is done.
- Adenovirus and parvovirus B19 perimyocarditis
- Preferred regimen: Immunoglobulin 10 g intravenously at day 1 and 3 for 6–8 hours
- Note: Symptomatic treatment is given to the patients with viral pericarditis while in large effusions and cardiac tamponade pericardiocentesis is necessary. The use of corticosteroid therapy is contraindicated except in patients with secondary tuberculous pericarditis, as an adjunct to tuberculosis treatment. Drainage, if needed is done.
- ↑ Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y; et al. (2004). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology". Eur Heart J. 25 (7): 587–610. doi:10.1016/j.ehj.2004.02.002. PMID 15120056.